BAB-59240-51439
1 vaccination
8 coded responses
16 check-ins
7 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 495 / MI
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- FNG-89770-12660
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Registered in v-safe
-
2022-06-24
Dose 1 — Moderna
- 2022-06-24
- 2022-06-25
-
2022-06-26
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Insomnia — Feeling: GoodFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: Poor · Fever · Sleepiness, Irritability/crying · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness · Be unable to work or attend schoolUnder 3 check-in
-
2022-06-29
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Nausea — Feeling: Fair · Fever · Irritability/cryingFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
- 2022-06-30
- 2022-07-01
- 2022-07-08
- 2022-07-15
- 2022-07-22
-
2022-07-29
Survey response — day 35, dose 1, under 3MedDRA: Cough, Lacrimation increased, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny nose, watery eyes, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Survey response — day 42, dose 1, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Survey response — 3 months, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Survey response — 6 months, dose 1, under 3MedDRA: Nasopharyngitis, Respiratory syncytial virus infection, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: RSV diagnosis. A few weeks later a runny nose and standard cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Report sent to call center — 6 months, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-12-27
-
2023-06-25
Survey response — 12 months, dose 1, under 3MedDRA: Cough, Intussusception, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Insomnia
Systemic reaction (other): Runny nose
Systemic reaction (other): Nausea
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Runny nose, watery eyes, cough
Release 12 (Under 3) — day 42, dose 1, under 3
Symptoms: Cough, congestion, runny nose
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: Runny nose
Release 12 (Under 3) — 6 months, dose 1, under 3
Symptoms: RSV diagnosis. A few weeks later a runny nose and standard cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Intussusception | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release